Exparel 133MG/10ML 10S
Ended Awarded
- Contract number
- SPE2DX25FKVUY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,536
Award facts
- Contract value 100% obligated
- $7,536.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $7,536.10 with an ultimate completion date of August 14, 2025, awards DMS Pharmaceutical Group Inc. a contract to supply EXPAREL 133MG/10ML in quantities of 10 units. The award was issued on July 31, 2025, under a firm fixed-price delivery order structure with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. The funding agency is the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting military health facilities worldwide. EXPAREL, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management, represents a specialized pharmaceutical product within the broader contract's scope covering branded and generic prescription drugs, biologics, and medical consumables. As a long-established federal contractor registered in the System for Award Management since 2001, DMS Pharmaceutical Group has positioned itself as a critical supplier within the federal pharmaceutical supply chain for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DX25FKVUY?
SPE2DX25FKVUY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 31, 2025.
How much is contract SPE2DX25FKVUY worth?
The government has obligated $7,536 on SPE2DX25FKVUY.
Is contract SPE2DX25FKVUY an order under another contract?
Yes. SPE2DX25FKVUY is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVUY competed?
The extent of competition for SPE2DX25FKVUY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award